Wayne Astridge, Chair of the East of England Board, said: “This is a crucial moment for the East of England. Cambridge has ...
Bio-engineering business Neobe Therapeutics, based at Stevenage Bioscience Catalyst, has secured a seed round of $6.8 million ...
The farming industry has no shortage of innovation, but the challenge is turning promising technology into practical ...
Secretary of State for Transport Heidi Alexander, saw first-hand how London Stansted Airport's transformation programme will ...
What does it take to turn world-class science into a commercial success story? For KluraLabs, the journey has taken the ...
Cambridge biotech Epitopea doses first patient in its UK Phase 1 clinical trial of CryptiVax-1001, a novel mRNA cancer ...
Cambridge biotech T-Therapeutics secures $133M in Series B funding co-led by Advent Life Sciences and British Business Bank ...
The PEM Corporate Finance team demonstrated its reach way beyond Cambridge as it acted as lead adviser to shareholders of ...
Kate Wood, Planning Director, Property Agency, BTG Eddisons unpicks some salient points of the NPPF when it comes to ...
PwC’s latest UK M & A research shows that deal value more than doubled in the first half of 2026, reaching £134.7 billion, while the number of announced transactions fell by almost 13 per cent to ...
AbbVie has expanded its Oxford R&D facility with a new 12,000 sq ft site, scaling UK research in immunology, neuroscience, ...
Arm reports record Q2 revenue of $1.44B, up 27% on surging AI compute demand, cloud chip market share crossing 50%, and early ...